Jobs / United States / Astrazeneca Pharmaceuticals Lp
Medical Director, Dyslipidemia
Astrazeneca Pharmaceuticals Lp · 🇺🇸 US - Wilmington - DE
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles15 certified filings for “Associate Director Oncology Outcomes Research” (Medical Scientists, Except Epidemiologists) in MD: $126k–$185k, median $140k. Most were filed at wage level II (47%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
Location: Wilmington, Delaware Hybrid: 3 days a week onsite At AstraZeneca, we work together across global boundaries to make an impact and find answers to challenges. We do this with the utmost integrity even in the most difficult situations because we are committed to doing the right thing. We continuously forge partnerships that help pursue world-class medicines in new ways, combining our people’s exceptional skills with those of people from all over the globe. The Medical Director – Dyslipidemia supports the development and execution of US Medical strategy for dyslipidemia and related assets. This role translates disease area and brand priorities into actionable medical execution plans, coordinates cross-functional execution, and helps ensure medical activities are aligned to clinical, scientific, customer, healthcare environment, and business needs. The role requires understanding of the disease area and the evolving US healthcare environment. It also requires inspiring change at scale through coordinated medical strategy, external scientific engagement, and transforming care initiatives. It is a key medical role that reports directly to the Medical Head – Dyslipidemia, within the BioPharmaceuticals Business Unit’s US Medical CVRM franchise. What you’ll do: • Lead the development, delivery, and evolution of disease area and brand medical execution strategies and plans • Through partnership and innovative thinking, identify external insights, customer needs, healthcare environment trends and opportunities to transform care that inform medical planning and execution • Lead the development and execution of scalable and sustainable transforming care initiatives aligned to disease area and medical strategic priorities. • Identify and advance opportunities to accelerate adoption of evidence-based care through partnerships with healthcare systems, scientific societies, quality organizations, and other external collaborators. • Coordinate cross-functional medical initiatives across Medical Affairs, Commercial, HEOR, Market Access, R&D, Field Medical and other partners to ensure aligned execution and enable large-scale change in care delivery • Maintain and strengthen key External Scientific Engagement (ESE) relationships across healthcare systems and other collaborators to advance disease area priorities, scientific exchange, and transforming care objectives. • Support the planning and implementation of product and disease area Advisory Boards, including objective development, collaborator engagement, insight generation, and follow-up action planning. • Contribute to publication plans, evidence generation initiatives, medical education activities and scientific communication deliverables • Partner with Senior Medical Directors and cross-functional teams to provide medical input for regulatory, labeling, preparation for product introduction, and lifecycle management activities Essential for the role: • MD, PhD, PharmD, or other advanced healthcare/scientific degree • Medical/clinical/scientific understanding of CVRM and dyslipidemia, with ability to apply disease area knowledge to medical planning, external engagement and execution • 3+ years of experience in the pharmaceutical industry, ideally in Medical Affairs, Evidence Generation, HEOR, Clinical Development or a relevant Medical / Healthcare field • Strategic and goal-oriented thinker with ability to translate complex medical priorities into clear plans, deliverables and approaches that inspire change at scale • Demonstrated track record delivering results in a complex matrix environment and supporting impactful medical initiatives • Proven ability to collaborate and build internal and external networks • Strong analytical mind-set and ability to quickly asses